New patent expiration for Bristol-myers Squibb drug EVOTAZ

Annual Drug Patent Expirations for EVOTAZ Evotaz is a drug marketed by Bristol-myers Squibb and is included in one NDA. It is available from one supplier. There are three patents…

The post New patent expiration for Bristol-myers Squibb drug EVOTAZ appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog